Dublin, Sept. 22, 2023 (GLOBE NEWSWIRE) -- The "Global Insulin Syringes Market 2022-2026" report has been added to ResearchAndMarkets.com's offering.
The global Insulin Syringes Market is on the cusp of substantial growth, with projections indicating an impressive increase of $408.67 million during the period from 2022 to 2026. This growth trajectory is marked by a robust Compound Annual Growth Rate (CAGR) of 4.69% throughout the forecast period.
The comprehensive report on the Insulin Syringes Market offers a holistic analysis, encompassing market size and forecasts, emerging trends, growth drivers, challenges, and a detailed vendor analysis featuring approximately 25 key vendors. With an up-to-date analysis of the current global market scenario, the report explores the latest trends, driving forces, and overall market dynamics.
Key Drivers for Market Growth:
The market's growth is driven by several key factors, including the increasing global burden of diabetes, favorable government initiatives, and the availability of diabetes self-management education programs. As diabetes continues to be a global health concern, the demand for insulin syringes is expected to rise significantly.
Insulin Syringes Market Segmentation:
By Type
- Type 2 diabetes
- Type 1 diabetes
By Geographical Landscape
- North America
- Europe
- APAC
- South America
- Middle East and Africa
Key Growth Factors:
The report identifies the increase in awareness programs for diabetes as one of the primary drivers fueling the growth of the Insulin Syringes Market in the coming years. Additionally, the market is expected to benefit from rising strategic partnerships aimed at boosting insulin syringe sales and an increasing focus on smart insulin syringes.
Report Highlights:
- Insulin Syringes Market Sizing
- Insulin Syringes Market Forecast
- Insulin Syringes Market Industry Analysis
Vendor Analysis:
The report provides a robust vendor analysis designed to help clients enhance their market positioning. It includes a detailed examination of several leading vendors in the Insulin Syringes Market, such as AdvaCare Pharma, ASP Healthcare Pty Ltd., Avantor Inc., B. Braun SE, Becton Dickinson and Co., Cardinal Health Inc, CODAN Medizinische Gerate GmbH and Co KG, Gerresheimer AG, Healthwarehouse.com Inc., Hi-Tech Medics Pvt Ltd., Hindustan Syringes and Medical Devices Ltd., LAC Healthcare Solutions, Nipro Corp., Novo Nordisk AS, Poly Medicure Ltd., SCHOTT AG, Smiths Group Plc, Terumo Corp., Thermo Fisher Scientific Inc., and UltiMed Inc.
The report also offers insights into upcoming trends and challenges that will influence market growth, enabling companies to strategize effectively and leverage forthcoming growth opportunities.
Research Methodology:
The study combines primary and secondary information, incorporating input from key industry participants. It presents a comprehensive market and vendor landscape while analyzing key parameters such as profitability, pricing, competition, and promotions.
A selection of companies mentioned in this report includes
- AdvaCare Pharma
- ASP Healthcare Pty Ltd.
- Avantor Inc.
- B. Braun SE
- Becton Dickinson and Co.
- Cardinal Health Inc
- CODAN Medizinische Gerate GmbH and Co KG
- Gerresheimer AG
- Healthwarehouse.com Inc.
- Hi-Tech Medics Pvt Ltd.
- Hindustan Syringes and Medical Devices Ltd.
- LAC Healthcare Solutions
- Nipro Corp.
- Novo Nordisk AS
- Poly Medicure Ltd.
- SCHOTT AG
- Smiths Group Plc
- Terumo Corp.
- Thermo Fisher Scientific Inc.
- UltiMed Inc.
For more information about this report visit https://www.researchandmarkets.com/r/8apcdg
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
